SYNERECA PHARMACEUTICALS

synereca-pharmaceuticals-logo

Synereca Pharmaceuticals, Inc. develops orally active drugs that restore the effectiveness of existing antibiotics. Its portfolio includes prototypic RecA inhibitors, which target various pathogenic bacteria/E. coli, including those responsible for lung, urinary tract, and skin infections, as well as weaponizable gram-positive and gram-negative pathogens through various bactericidal antibiotics. The company was incorporated in 2009 and is based in Chapel Hill, North Carolina.

#SimilarOrganizations #People #Financial #Website #More

SYNERECA PHARMACEUTICALS

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2009-01-01

Address:
Chapel Hill, North Carolina, United States

Country:
United States

Website Url:
http://www.synereca.com

Total Employee:
1+

Status:
Active

Contact:
919-929-5167

Email Addresses:
[email protected]

Total Funding:
2.34 M USD

Technology used in webpage:
SPF Amazon GStatic Google Static Content Amazon Ohio Region


Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

bionpharma-logo

BionPharma

BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.

epivax-logo

EpiVax

EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.

Current Employees Featured

scott-singleton_image

Scott Singleton
Scott Singleton Co-founder @ Synereca Pharmaceuticals
Co-founder

Founder


clayton-i-duncan_image

Clayton I. Duncan

scott-singleton_image

Scott Singleton

w-bennett-love_image

W. Bennett Love

Investors List

accele-venture-partners_image

Accele Venture Partners

Accele Venture Partners investment in Venture Round - Synereca Pharmaceuticals

oklahoma-seed-capital-fund_image

Oklahoma Seed Capital Fund

Oklahoma Seed Capital Fund investment in Venture Round - Synereca Pharmaceuticals

i2e_image

i2E

i2E investment in Venture Round - Synereca Pharmaceuticals

i2e_image

i2E

i2E investment in Debt Financing - Synereca Pharmaceuticals

accele-venture-partners_image

Accele Venture Partners

Accele Venture Partners investment in Debt Financing - Synereca Pharmaceuticals

Official Site Inspections

http://www.synereca.com

  • Host name: ec2-13-216-111-180.compute-1.amazonaws.com
  • IP address: 13.216.111.180
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Synereca Pharmaceuticals" on Search Engine